基本情報
- CAS
14051-33-3- 標準SMILES
O=C1CCC(c2ccccc2)(C2CCN(Cc3ccccc3)CC2)C(=O)N1- InChIKey
LQQIVYSCPWCSSD-UHFFFAOYSA-N- 分子式
- C23H26N2O2
- 平均分子量
- 362.5 g/mol
- 単同位体質量
- 362.19942808
概要
Benzetimide is a member of piperidines.
名称と識別子
- 優先名称
- Benzetimide
- IUPAC
- 3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione
- 現地名
- 3-フェニル-1'-(フェニルメチル)-3,4'-ビピペリジン-2,6-ジオン
- 英語名
- 3-(1-benzyl-4-piperidyl)-3-phenyl-piperidine-2,6-dione
- 分子式
- C23H26N2O2
- 分子量
- 362.46
名称と別名
Benzetimide14051-33-3BenzetimidumSpasmentalbencetimida2-(1-Benzyl-4-piperidyl)-2-phenylglutarimideDTXSID2046173B987T0L5FXDTXCID00261732-[1-BENZYL-4-PIPERIDYL]-2-PHENYLGLUTARIMIDE(3,4'-Bipiperidine)-2,6-dione, 3-phenyl-1'-(phenylmethyl)-RefChem:118121
名称をさらに表示
3-フェニル-1'-(フェニルメチル)-3,4'-ビピペリジン-2,6-ジオンベンゼチミド2-(1-ベンジル-4-ピペリジル)-2-フェニルグルタルイミド1'-ベンジル-3-フェニル-[3,4'-ビピペリジン]-2,6-ジオン3-フェニル-1′-(フェニルメチル)-3,4′-ビピペリジン-2,6-ジオンBenzezimida( -)-BenzetimidBENZETIMIDE(WXG01746)Benzetimidum [inn-latin]Benzezimida [inn-spanish]3-Phenyl-1'-(phenylmethyl)-3,4'-bipiperidine-2,6-dione3-(1-benzyl-4-piperidyl)-3-phenyl-piperidine-2,6-dione(Rs)-3-(1-benzyl-4-piperidyl)-3-phenyl-2,6-piperidindion
Benzetimide [INN]3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione1'-Benzyl-3-phenyl-[3,4'-bipiperidine]-2,6-dioneBenzetimide (INN)119391-55-8CHEMBL10272MFCD00242705(+/-)-Benzetimide
物性
構造計算による物性
- XLogP
- 3.1
- 極性表面積
- 49.4 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 3
- 回転可能結合数
- 4
- 重原子数
- 27
- 形式電荷
- 0
- 複雑度
- 528
物理化学的性質
- 融点
- 156 · 156-159°
化学と産業
薬理情報
ATC CodeQA - Alimentary tract and metabolism
MeSH Pharmacological Classification
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.
上流・下流製品情報
下流製品
サプライヤー1 社
上海凯裕医药科技有限公司17317130613 · [email protected]
関連反応
0 件
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…